Rana Therapeutics Inc - Cambridge, Massachusetts 02139

Rana Therapeutics Inc is categorized under Commercial Biotechnical Research in Cambridge, MA .

Business Name: Rana Therapeutics Inc
Contact Person: Arthur M Krieg
Address: 790 Memorial Drive # 203, Cambridge, Massachusetts 02139
Phone Number: (617) 945-7361
Website Address: ranarx.com
Annual Revenue (USD): $500.000 to $999.999
Founding Year: 2011
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Commercial Biotechnical Research
SIC Code: 8731
NAICS Code: 541711
Share This Business:
Related Businesses: Infinity Discovery Inc - Cambridge, MA 02139
Babyboost Inc - Cambridge, MA 02139
Visolis Inc - Cambridge, MA 02139
Volvox Biologic Inc - Cambridge, MA 02139
Manus Biosynthesis - Cambridge, MA 02139
Human Metabolome Technologies - Cambridge, MA 02139
Epi Zyme Inc - Cambridge, MA 02139
Mersana Therapeutics Inc - Cambridge, MA 02139
Dna Medicine Institute Inc - Cambridge, MA 02139
Galenea Corp - Cambridge, MA 02139
Bluebird Bio Inc - Cambridge, MA 02139
Ariad Corp - Cambridge, MA 02139
Alantos Pharmaceuticals Inc - Cambridge, MA 02139
Mindsjungle Inc - Cambridge, MA 02139
Warp Drive Bio LLC - Cambridge, MA 02139

The company Rana Therapeutics Inc provides B2B services in the form of Commercial Biotechnical Research from its single location in Massachusetts. 1 to 4 employees work for Rana Therapeutics Inc, and the business now earns $500.000 to $999.999 per annum.

Rana Therapeutics Inc was launched in 2011 and is classified under SIC code and category 8731 , and NAICS number and grouping 541711 . To contact Rana Therapeutics Inc, please call Arthur M Krieg with the phone number (617) 945-7361 or visit its single location at 790 Memorial Drive # 203 in Cambridge, Massachusetts 02139.

The location of the single location can also be found using the coordinates 42.35931,-71.115476. Read more details about this business on the webpage ranarx.com or follow the company’s social media accounts, on Twitter and on Facebook.